Tanja Obradovic, Therapeutic Strategy Lead of Oncology at Novotech, Senior Advisor of Oncology Drug Development at HopeAI, shared a post on LinkedIn:
“American Society of Clinical Oncology (ASCO) annual meeting is fast approaching and final abstract texts will be available on May 21 at 05:00 PM ET.
Next week I’ll be there with outstanding Novotech team and glad to meet in person with colleagues from Pharma and Biotech who would like to discuss clinical development plans. Feel free to send me a message or use link below and we can find time to talk.
Link for meeting with Novotech team.”
Other articles about ASCO on OncoDaily.